Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -808 | -512 | -251 | -2 | -201 |
| Depreciation Amortization | 211 | 128 | 58 | N/A | 86 |
| Accounts payable and accrued liabilities | 0 | -1 | 26 | 1 | -8 |
| Other Working Capital | 22 | 22 | -19 | 2 | 263 |
| Other Operating Activity | 25 | 15 | -26 | -1 | -253 |
| Operating Cash Flow | $-549 | $-347 | $-212 | $0 | $-114 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11 | -1 | -1 | N/A | N/A |
| Net Acquisitions | N/A | N/A | N/A | N/A | 100 |
| Investing Cash Flow | $-11 | $-1 | $-1 | $N/A | $100 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 925 | 450 | 350 | N/A | 40 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -33 |
| Financing Cash Flow | $925 | $450 | $350 | $N/A | $7 |
| Beginning Cash Position | N/A | N/A | N/A | N/A | 8 |
| End Cash Position | 365 | 102 | 137 | N/A | 1 |
| Net Cash Flow | $365 | $102 | $137 | $0 | $-7 |
| Free Cash Flow | |||||
| Operating Cash Flow | -549 | -347 | -212 | 0 | -114 |
| Capital Expenditure | -11 | -1 | -1 | N/A | N/A |
| Free Cash Flow | -560 | -348 | -214 | 0 | -114 |